BioWink
For individuals with menstrual cycles seeking data-driven insights into reproductive health, fertility, and hormonal patterns.
Snapshot
Who is BioWink?
Providing science-based menstrual health tracking and reproductive insights with a focus on data privacy and biometric integration.
Target audience
Portfolio
Free 1Last updated
Clue Period & Cycle Tracker
v276.0
6mo ago
Publisher DNA
What defines BioWink?
Publisher DNA
Primary focus
Menstrual health and reproductive tracking
Scale
indie
Target audience
Individuals with menstrual cycles seeking data-driven insights into reproductive health, fertility, and hormonal patterns.
Signature Patterns
- •Science-backed approach to reproductive health tracking
- •Strong emphasis on GDPR-compliant data privacy and security
- •Freemium monetization via 'Clue Plus' subscription tiers
- •Integration with wearable hardware for biometric data collection
- •High update frequency with a bi-weekly release cadence
Portfolio momentum
Maintained an intense development pace with 12 updates for its flagship title over the last 6 months.
Portfolio
What does BioWink ship?
Apps
1 app analysed
Research-driven content provides a defensible barrier against generic trackers
- Long-term users value the accurate cycle tracking and clear, science-backed health information provided by the app
- Aggressive and constant pop-up advertisements for premium subscriptions disrupt the core logging experience for free users
Distributed across 11 markets, strongest in Europe.
Based on 1 of 1 app with localized market data · last scanned .
Americas (3)
- Brazil1 / 1
- Mexico1 / 1
- United States1 / 1
Europe (7)
- France1 / 1
- Germany1 / 1
- Italy1 / 1
- Netherlands1 / 1
- Portugal1 / 1
›+2 more europe markets
- Spain1 / 1
- Sweden1 / 1
Asia-Pacific (1)
- Japan1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
35/100
Avg sentiment score
Rivals
Who does BioWink compete with?
The rivals identified
Nemeses(1)
Both apps target individuals tracking menstrual cycles, fertility, and pregnancy, competing directly for the same user base through freemium models that gate advanced health insights behind subscription tiers.
Contenders(10)
Both applications target individuals monitoring menstrual cycles and fertility, creating direct competition for users seeking reproductive health tracking tools.
My Cycle competes by offering a free, no-subscription alternative for users alienated by the aggressive paywalling of historical data in Clue Period & Cycle Tracker.
Both applications compete for the same demographic of users managing menstrual health and fertility, with both relying on hybrid monetization models that gate historical data behind subscriptions.
Both applications target individuals tracking menstrual cycles and fertility, competing directly for the same user base by offering cycle prediction and symptom logging features.
Both applications target users seeking cycle and reproductive health tracking, competing directly for the same demographic while both currently face user backlash regarding aggressive monetization shifts.
Both applications target users tracking reproductive health and cycles, competing directly for the same demographic through subscription-gated health insights and daily symptom logging.
Cycles competes by offering a privacy-focused, minimalist alternative to Clue, specifically targeting users who prioritize collaborative cycle tracking through its Partner Connect feature.
Both applications target the same menstrual cycle tracking demographic with free-to-use core functionality, creating direct competition for users seeking reliable cycle and ovulation predictions.
Both apps target individuals tracking menstrual cycles and fertility, competing directly for users seeking cycle management tools.
IVY targets the same reproductive health demographic as Clue, offering overlapping cycle tracking and fertility monitoring features within a free-to-use model.
Same space(15)
This calculator offers a simplified, ad-supported cycle tracking experience, attracting casual users who prefer a lower barrier to entry than Clue.
Femometer targets the high-intent conception segment by integrating physical test result logging with machine learning cycle predictions.
Premom captures the high-intent fertility market via physical test-strip integration, serving as a specialized alternative to Clue's general cycle tracking.
This app attempts to bridge the gap between fertility tracking and daily wellness, offering a broader engagement model than Clue's cycle-centric design.
Users report: Luna differentiates through a privacy-first, partner-inclusive model, appealing to users who reject the data-harvesting practices of mainstream trackers like Clue.
This app provides a basic fertility calculator, serving as a lightweight alternative for users who find Clue's feature set overly complex.
This app serves as a private, local-only alternative for users who prioritize data security over the social or cloud-based features found in Clue.
Users report: Luna targets the teen demographic with educational content, acting as a specialized entry point for users who may eventually transition to Clue.
Natural Cycles competes by offering a clinical-grade contraceptive alternative, attracting users who require regulatory-cleared reliability over Clue's general health insights.
This app focuses on the pregnancy-tracking segment, providing a specialized tool for users transitioning from cycle tracking to gestation monitoring.
This tracker provides a broad suite of reproductive health tools, serving as a direct functional substitute for Clue's core tracking features.
Ovia serves as a broader reproductive health platform, offering pregnancy and menopause support that extends beyond Clue's primary cycle-tracking focus.
Sleep Cycle addresses the sleep-quality aspect of reproductive health, serving as a non-wearable utility that coexists with Clue's symptom tracking.
Fertility Friend provides a technical, chart-heavy alternative for users who prioritize detailed data analysis over the simplified UI of Clue.
Wanted Fertility targets the clinical-grade fertility market, providing a structured protocol-based experience for users managing medical journeys.
New entrants(1)
Vea focuses on phase-based lifestyle guidance, offering a more prescriptive approach to cycle management than Clue's data-logging focus.
The Analyst's Read
The bottom line on BioWink
Bottom line
BioWink is a specialized single-app publisher that has successfully defended its niche by prioritizing data sovereignty and clinical utility. Their high weighted rating and consistent update velocity signal a mature product with strong user retention.
Frequently asked questions
How many apps does BioWink publish?
What kind of apps does BioWink make?
What is BioWink's top app?
In how many countries are BioWink's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 0
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- yes